CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Antinuclear Antibody Testing for Systemic Lupus Erythematosus or Connective Tissue Disease

Last updated: January 26, 2021
Project Number: RB1545-000
Product Line: Rapid Response
Research Type: Other Diagnostics
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of antinuclear antibody testing in patients without symptoms for systemic lupus erythematosus or other connective tissue diseases?
  2. What are the evidence-based guidelines regarding antinuclear antibody testing in patients without symptoms for systemic lupus erythematosus or other connective tissue diseases?

Key Message

No relevant clinical evidence or evidence-based guidelines were identified regarding the clinical effectiveness of antinuclear antibody testing in patients without symptoms for systemic lupus erythematosus or other connective tissue diseases.